Scientific Opinion on the substantiation of health claims related to a C12 peptide (Phe-Phe-Val-Ala-Pro-Phe-Pro-Glu-Val-Phe-Gly-Lys) and maintenance of normal blood pressure (ID 1483, 3130) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Published:
Adopted:
Wiley Online Library
Full article:
Meta data
Keywords
C12-peptide, blood pressure, health claims
On request from
European Commission
Question Number
EFSA-Q-2008-2220
EFSA-Q-2008-3862
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren, and Hans Verhagen.
Contact
Abstract
No abstract available
© European Food Safety Authority, 2010